US Stock MarketDetailed Quotes

Applied Therapeutics (APLT)

Watchlist
  • 0.1014
  • -0.0046-4.34%
Trading Jan 23 11:26 ET
14.63MMarket Cap-1.01P/E (TTM)

Applied Therapeutics (APLT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
21.13%-18.4M
9.98%-20.34M
-51.43%-28.64M
-52.80%-84.31M
-14.49%-19.47M
-58.43%-23.33M
-37.34%-22.6M
-170.54%-18.91M
29.35%-55.17M
-7.00%-17.01M
Net income from continuing operations
72.31%-18.99M
-836.02%-21.33M
74.00%-21.83M
11.81%-105.62M
216.79%44.01M
-61.89%-68.59M
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
Operating gains losses
-94.10%2.37M
93.68%-1.44M
-104.90%-3.1M
-91.55%4.78M
-548.43%-76.06M
47.33%40.19M
-277.64%-22.75M
13,619.19%63.41M
85,616.67%56.57M
498.64%16.96M
Depreciation and amortization
6.73%111K
-9.84%110K
-13.33%104K
20.34%426K
1,233.33%80K
-11.86%104K
5.17%122K
5.26%120K
-20.09%354K
-94.74%6K
Other non cash items
2.86%-102K
80.86%-98K
-136.54%-95K
-92.89%124K
-77.10%481K
13.22%-105K
42.08%-512K
-59.94%260K
-44.58%1.74M
-39.55%2.1M
Change In working capital
-198.16%-2.93M
106.52%314K
-357.61%-5.2M
274.88%2.52M
222.08%5.49M
261.06%2.99M
-130.56%-4.81M
-242.48%-1.14M
83.71%-1.44M
15,381.82%1.7M
-Change in prepaid assets
-4,226.59%-15.62M
21.94%-886K
427.27%1.04M
-130.98%-580K
-47.49%1.24M
-67.91%-361K
-1,301.23%-1.14M
-73.37%-319K
421.45%1.87M
278.74%2.35M
-Change in payables and accrued expense
279.09%12.69M
132.62%1.2M
-10,488.14%-6.25M
287.15%3.86M
692.75%4.25M
295.96%3.35M
-570.13%-3.68M
-106.47%-59K
68.58%-2.06M
33.24%-717K
-Change in other current liabilities
--0
--0
--0
-357.29%-759K
--0
--0
--0
-1,184.29%-759K
-36.42%295K
-85.34%68K
-Change in other working capital
----
----
----
----
----
----
----
----
50.21%-1.55M
--0
Cash from discontinued investing activities
Operating cash flow
21.13%-18.4M
9.98%-20.34M
-51.43%-28.64M
-52.80%-84.31M
-14.49%-19.47M
-58.43%-23.33M
-37.34%-22.6M
-170.54%-18.91M
29.35%-55.17M
-7.00%-17.01M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
5.33%13.87M
0
Net investment purchase and sale
----
----
----
--0
--0
--0
--0
--0
5.33%13.87M
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
5.33%13.87M
--0
Financing cash flow
Cash flow from continuing financing activities
-75K
0
0
52.67%113.81M
0
0
-105.80%-1.69M
18,668.65%115.5M
169.18%74.54M
3,256.06%29.45M
Net issuance payments of debt
--0
--0
--0
83.26%-311K
--0
--0
--0
50.00%-311K
43.23%-1.86M
50.16%-465K
Net common stock issuance
---1K
--0
--0
62.36%104.75M
--0
--0
-107.18%-2M
--106.75M
131.97%64.51M
--29.91M
Proceeds from stock option exercised by employees
--20K
--0
--0
-9.40%9.37M
--0
--0
1,376.19%310K
--9.06M
21,002.04%10.34M
--3K
Net other financing activities
----
----
----
----
----
----
----
----
-50.21%1.55M
--0
Cash from discontinued financing activities
Financing cash flow
---75K
--0
--0
52.67%113.81M
--0
--0
-105.80%-1.69M
18,668.65%115.5M
169.18%74.54M
3,256.06%29.45M
Net cash flow
Beginning cash position
-75.10%30.42M
-65.35%50.76M
59.12%79.4M
199.56%49.9M
163.95%98.87M
243.10%122.2M
539.19%146.48M
199.56%49.9M
-69.09%16.66M
-7.26%37.46M
Current changes in cash
20.81%-18.48M
16.25%-20.34M
-129.65%-28.64M
-11.25%29.5M
-256.49%-19.47M
-1,367.25%-23.33M
-291.25%-24.29M
1,442.91%96.59M
189.28%33.24M
152.43%12.44M
End cash Position
-87.92%11.95M
-75.10%30.42M
-65.35%50.76M
59.12%79.4M
59.12%79.4M
163.95%98.87M
243.10%122.2M
539.19%146.48M
199.56%49.9M
199.56%49.9M
Free cash flow
21.13%-18.4M
9.98%-20.34M
-51.43%-28.64M
-52.80%-84.31M
-14.49%-19.47M
-58.43%-23.33M
-37.34%-22.6M
-170.54%-18.91M
29.35%-55.17M
-7.00%-17.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 21.13%-18.4M9.98%-20.34M-51.43%-28.64M-52.80%-84.31M-14.49%-19.47M-58.43%-23.33M-37.34%-22.6M-170.54%-18.91M29.35%-55.17M-7.00%-17.01M
Net income from continuing operations 72.31%-18.99M-836.02%-21.33M74.00%-21.83M11.81%-105.62M216.79%44.01M-61.89%-68.59M109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M
Operating gains losses -94.10%2.37M93.68%-1.44M-104.90%-3.1M-91.55%4.78M-548.43%-76.06M47.33%40.19M-277.64%-22.75M13,619.19%63.41M85,616.67%56.57M498.64%16.96M
Depreciation and amortization 6.73%111K-9.84%110K-13.33%104K20.34%426K1,233.33%80K-11.86%104K5.17%122K5.26%120K-20.09%354K-94.74%6K
Other non cash items 2.86%-102K80.86%-98K-136.54%-95K-92.89%124K-77.10%481K13.22%-105K42.08%-512K-59.94%260K-44.58%1.74M-39.55%2.1M
Change In working capital -198.16%-2.93M106.52%314K-357.61%-5.2M274.88%2.52M222.08%5.49M261.06%2.99M-130.56%-4.81M-242.48%-1.14M83.71%-1.44M15,381.82%1.7M
-Change in prepaid assets -4,226.59%-15.62M21.94%-886K427.27%1.04M-130.98%-580K-47.49%1.24M-67.91%-361K-1,301.23%-1.14M-73.37%-319K421.45%1.87M278.74%2.35M
-Change in payables and accrued expense 279.09%12.69M132.62%1.2M-10,488.14%-6.25M287.15%3.86M692.75%4.25M295.96%3.35M-570.13%-3.68M-106.47%-59K68.58%-2.06M33.24%-717K
-Change in other current liabilities --0--0--0-357.29%-759K--0--0--0-1,184.29%-759K-36.42%295K-85.34%68K
-Change in other working capital --------------------------------50.21%-1.55M--0
Cash from discontinued investing activities
Operating cash flow 21.13%-18.4M9.98%-20.34M-51.43%-28.64M-52.80%-84.31M-14.49%-19.47M-58.43%-23.33M-37.34%-22.6M-170.54%-18.91M29.35%-55.17M-7.00%-17.01M
Investing cash flow
Cash flow from continuing investing activities 000005.33%13.87M0
Net investment purchase and sale --------------0--0--0--0--05.33%13.87M--0
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--05.33%13.87M--0
Financing cash flow
Cash flow from continuing financing activities -75K0052.67%113.81M00-105.80%-1.69M18,668.65%115.5M169.18%74.54M3,256.06%29.45M
Net issuance payments of debt --0--0--083.26%-311K--0--0--050.00%-311K43.23%-1.86M50.16%-465K
Net common stock issuance ---1K--0--062.36%104.75M--0--0-107.18%-2M--106.75M131.97%64.51M--29.91M
Proceeds from stock option exercised by employees --20K--0--0-9.40%9.37M--0--01,376.19%310K--9.06M21,002.04%10.34M--3K
Net other financing activities ---------------------------------50.21%1.55M--0
Cash from discontinued financing activities
Financing cash flow ---75K--0--052.67%113.81M--0--0-105.80%-1.69M18,668.65%115.5M169.18%74.54M3,256.06%29.45M
Net cash flow
Beginning cash position -75.10%30.42M-65.35%50.76M59.12%79.4M199.56%49.9M163.95%98.87M243.10%122.2M539.19%146.48M199.56%49.9M-69.09%16.66M-7.26%37.46M
Current changes in cash 20.81%-18.48M16.25%-20.34M-129.65%-28.64M-11.25%29.5M-256.49%-19.47M-1,367.25%-23.33M-291.25%-24.29M1,442.91%96.59M189.28%33.24M152.43%12.44M
End cash Position -87.92%11.95M-75.10%30.42M-65.35%50.76M59.12%79.4M59.12%79.4M163.95%98.87M243.10%122.2M539.19%146.48M199.56%49.9M199.56%49.9M
Free cash flow 21.13%-18.4M9.98%-20.34M-51.43%-28.64M-52.80%-84.31M-14.49%-19.47M-58.43%-23.33M-37.34%-22.6M-170.54%-18.91M29.35%-55.17M-7.00%-17.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More